DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...

Baxter has received an FDA clearance for its latest, portable dialysis machine designed to connect directly with electronic medical records for patients’ prescriptions and treatment data. The ...

Baxter International Inc. BAX recently introduced the Sharesource Analytics 1.0 premium module, which is the next generation of digital health for home-based peritoneal dialysis (“PD”) patients.

Baxter International Inc. BAX recently received U.S. FDA clearance of its next-generation Artificial Kidney 98 (AK 98) dialysis machine, which can be used simultaneously with the company’s novel ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International, Inc. (NYSE:BAX), a global innovator in renal care, announced today the launch of the PD Excellence Academy, a new virtual training platform and ...

DEERFIELD - Baxter International Inc. said U.S. Food and Drug Administration has approved its next-generation Artificial Kidney 98 dialysis machine, which is designed to be a portable and easy-to-use ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine ...

Please provide your email address to receive an email when new articles are posted on . Baxter International plans to spin off its renal care and acute therapies global business units into an ...